Abstract 2111P
Background
Psychometric assessment tools are widely available but underutilized in daily oncology practice. The aim of this study was to evaluate the role of multiple psychometric scales in identifying cancer patients in distress who need Psycho-Oncology management.
Methods
Colorectal cancer patients were prospectively asked to complete a survey including 3 psychometric scales (GAD-7, PHQ-9, PC-PTSD-5). Those scoring high on at least one scale (GAD-7 score ≥ 10, PHQ-9 score ≥ 10, PC-PTSD-5 score ≥ 4) were offered referral to the Psycho-Oncology service. Those accepting the referral were further triaged by members of this service via a standardized semi-structured interview. Patients were divided into three groups: those accepted by the Psycho-Oncology service, those declined the referral and those discharged from the service with no need for further intervention. Outcomes were compared with the analysis of variance test (ANOVA).
Results
Fifty-four patients (30 females) of median age 60 years (range 36-81) were prospectively evaluated. 20 patients (37%) reported their cancer was under control, 15 (28%) believed they had progressive disease, while 19 (35%) were uncertain. Approximately half patients (26; 48%) referred a prior history of a mental condition. The mean (±SE) scores for each psychometric scale were 10.96 (± 0.78), 12.79 (± 0.82), and 1.07 (± 0.21), respectively for GAD-7, PHQ-9, PC-PTSD-5. Thirty-four patients (63%) scored high on GAD-7, 40 (74%) on PHQ-9 and 8 (15%) on PC-PTSD-5. Almost half of the patients declined a referral (25, 46%), 22 (41%) were assessed by a Psycho-Oncologist and managed accordingly and 7 (13%) were discharged after the initial tirage. There was no statistically significant difference in the mean psychometric scores between the three identified groups (p<0.05).
Conclusions
Psychometric scales are useful screening tools to identify distress but cannot differentiate between general distress and psychological/psychiatric symptoms requiring specialist intervention. Psychometric scales should be used in conjunction with semi-structured interviews. The ‘screen and triage’ model should be further investigated as part of an integrated care model, to signpost cancer patients to appropriate support services.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Servier.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06